Interview with Dr. George Simon, MD, FACP, FCCP at MD Anderson and Dr. Rebecca Suk Heist, MD, MPH at Massachusetts General Hospital Cancer Center
At the LUNGevity Live Lung Cancer Town Meeting, Andrew Schorr interviews Dr. Simon and Dr. Heist about clinical trials. Dr. Simon explains how clinical trials can give you access to tomorrow’s medicine today. For example, Bevacizumab was first introduced in a clinical trial in 1999, but did not get approved or become standard of care until 2006/2007. Next. Dr. Heist explains how the phases of clinical trials.
- Phase 1: Testing to find the right dosage in people
- Phase 2: Once the recommended dose is know, testing is done to find out the real response rate and real efficacy in people
- Phase 3: Once the dose and results are known, a randomized study is done to compare it to the standard of care to see if it really is better
Watch the full video below to hear all about clinical trials from two lung cancer experts.